BNET Industries
Last Fiscal Year Sales:$2.2B
- Public
- CH
Dow Jones Description
Pharmaceutical Products Mfr & Marketer & Logistic Services
CFO & Head, Finance
FRITZ HIRSBRUNNERNumber of Employees 956
Peer Companies
NAICS Code Administrative Management and General Management Consulting Services: 541611
News & Analysis
Filter by
galenica ltd. - All News and Analysis
Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
- 2008-09-16
BAD HOMBURG, Germany -- Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the closing of an exclusive license agreement with Luitpold Pharmaceuticals, Inc., and its subsidiary American Regent, Inc. for the manufacture and distribution of intravenous (I.V.) iron products in...
Fresenius Medical Care Signs Agreements for Intravenous Iron Products
- 2008-07-09
BAD HOMBURG, Germany -- Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced that it signed exclusive license agreements for the intravenous IV Iron products Venofer([R]) iron sucrose and Ferinject([R]) ferric carboxymaltose to treat iron deficiency anemia experienced by dialysis patients....
Galenica acquisition finalized.
- 2004-06-01
Australian Cancer Technology (Sydney, Australia) chairman Roger Aston and managing director Paul Hopper announced from New York that due diligence on the proposed US$5 million Galenica Pharmaceuticals (Birmingham, AL) acquisition was completed satisfactorily and final documentation signed today. The acquisition is now subject only to...
AustCancer's Galenica signs materials transfer agreement with Memorial Sloan-Kettering.
- 2004-06-01
Australian Cancer Technology (Sydney, Australia) announced that its soon to be acquired US business, Galenica Pharmaceuticals, had signed an agreement with the prestigious Memorial Sloan-Kettering Cancer Center (New York, NY) for the use of Galenica's lead product, the GPI-0100 adjuvant, in a series of clinical trials....
Galenica awarded patent for chemically modified immune enhancing agents.(Brief Article)
- 2001-07-01
Galenica Pharmaceuticals, Inc. (Birmingham, AL; 205-982-8676) announced that the United States Patent and Trademark Office has issued United States Patent 6,262,029 "Chemically Modified Saponins and the Use Thereof as Adjuvants" that covers a new family of semi-synthetic immune enhancing saponin derivatives. Galenica's immune enhancing...
SuperGen and Galenica Pharmaceuticals announce anticancer collaboration
- 1996-11-25
EMERYVILLE, Calif.--BUSINESS WIRE--Nov. 25, 1996--SuperGen Inc. (NASDAQ: SUPG & SUPGW) and Galenica Pharmaceuticals Inc., both emerging pharmaceutical companies, announced they have agreed to a strategic collaboration aimed at the discovery and development of new anticancer drugs based on natural products. SuperGen will make an equity investment giving...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| FRITZ HIRSBRUNNER | CFO & Head, Finance |
| Anthony Coombs | Head, Pharma Division |
| Dr GIANNI ZAMPIERI | Head, Pharma |
| Dr MICHEL F TROYON | |
| Leiter Generaldirektion | |
| PHILIPPE MILLIET | Head, Health Division |
| PHILIPPE WEIGERSTORFER | Head, Corp Dev |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Aloys Von Graffenried | Board of Directors |
| Carl M. Meyer | Board of Directors |
| Jean-Francois Bonvin | Board of Directors |
| Jean-Luc Forni | Board of Directors |
| Kurt W. Briner | Board of Directors |
| Martin Breitenmoser | Board of Directors |
| Paul Fasel | Vice Chairman |
| Paul-Andre Nussbaumer | Board of Directors |
| Pierre Douaze | Board of Directors |
| Stefano Pessina | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | CFO & Head, Finance | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Head, Pharma Division | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Head, Pharma | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Head, Health Division | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Head, Corp Dev | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Hero | Former |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
Kurt W. Briner is the former President and Chief Executive Officer of Sanofi Pharma S.A. in Paris, France, a position he held from 1988 until his retirement in 2000, and he has nearly 32 years' experience in the pharmaceutical industry. Mr. Briner is currently also a director of Novo Nordisk Danmark and Galenica S.A., each a European-based pharmaceutical company. He attended Humanistisches Gymnasium in Basel and Ecole de Commerce in Basel and Lausanne.
| Organization | Position | Status |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | Chairman | Current |
| Om Pharma | Board Member | Current |
| Progenics Pharmaceuticals, Inc. | Board of Directors | Current |
| Galenica Ltd. | Board of Directors | Current |
| Novo Nordisk, Inc. | member | Former |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Vice Chairman | Current |
| Galenica Ltd. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS
IndustryTop Rated
